Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bradding

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Immunological Reviews|February 13, 2018
The controversial role of mast cells in fibrosisPeter Bradding, Gunnar Pejler
British Journal of Pharmacology|August 18, 2009
The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapyPeter Bradding, Heike Wulff
European Journal of Pharmacology|May 12, 2015
Mast cells in airway diseases and interstitial lung diseaseGlenn Cruse, Peter Bradding
Thorax|April 9, 2013
Ion channelsPeter Bradding, Heike Wulff
Advances in Immunology|September 28, 2017
β2-Adrenoceptor Function in AsthmaYassine Amrani, Peter Bradding
Current Opinion in Allergy and Clinical Immunology|November 13, 2009
Subclinical phenotypes of asthmaPeter Bradding, Ruth H Green
British Journal of Pharmacology|November 24, 2019
Ca<sup>2+</sup> signalling in fibroblasts and the therapeutic potential of K<sub>Ca</sub>3.1 channel blockers in fibrotic diseasesKaty M Roach, Peter Bradding
Advances in Experimental Medicine and Biology|June 30, 2011
Mast cells in lung inflammationElena P Moiseeva, Peter Bradding
Current Allergy and Asthma Reports|February 3, 2005
The re-emergence of the mast cell as a pivotal cell in asthma pathogenesisChristopher E Brightling, Peter Bradding
Translational Research : the Journal of Laboratory and Clinical Medicine|February 5, 2016
Mast cells and their activation in lung diseaseHarvinder Virk, Greer Arthur, Peter Bradding
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Immunological Reviews|February 13, 2018
The controversial role of mast cells in fibrosisPeter Bradding, Gunnar Pejler
British Journal of Pharmacology|August 18, 2009
The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapyPeter Bradding, Heike Wulff
European Journal of Pharmacology|May 12, 2015
Mast cells in airway diseases and interstitial lung diseaseGlenn Cruse, Peter Bradding
Thorax|April 9, 2013
Ion channelsPeter Bradding, Heike Wulff
Advances in Immunology|September 28, 2017
β2-Adrenoceptor Function in AsthmaYassine Amrani, Peter Bradding
Current Opinion in Allergy and Clinical Immunology|November 13, 2009
Subclinical phenotypes of asthmaPeter Bradding, Ruth H Green
British Journal of Pharmacology|November 24, 2019
Ca<sup>2+</sup> signalling in fibroblasts and the therapeutic potential of K<sub>Ca</sub>3.1 channel blockers in fibrotic diseasesKaty M Roach, Peter Bradding
Advances in Experimental Medicine and Biology|June 30, 2011
Mast cells in lung inflammationElena P Moiseeva, Peter Bradding
Current Allergy and Asthma Reports|February 3, 2005
The re-emergence of the mast cell as a pivotal cell in asthma pathogenesisChristopher E Brightling, Peter Bradding
Translational Research : the Journal of Laboratory and Clinical Medicine|February 5, 2016
Mast cells and their activation in lung diseaseHarvinder Virk, Greer Arthur, Peter Bradding
Pageof 17